Suggy Chrai

Suggy Chrai

Suggy’s Company

Advanstar

Employees: 1000

Website: http://www.advanstar.com

Advanstar Communications Inc. (www.advanstar.com) is a leading worldwide media company providing integrated marketing solutions for the Fashion, Life ... More » Advanstar Communications Inc. (www.advanstar.com) is a leading worldwide media company providing integrated marketing solutions for the Fashion, Life Sciences and Powersports industries. Advanstar serves business professionals and consumers in these industries with its portfolio of 147 events, 68 publications and directories, 267 electronic products and Web sites, as well as educational and direct marketing products and services. Market leading brands and a commitment to delivering innovative, quality products and services enables Advanstar to “Connect Our Customers With Theirs.” Advanstar has approximately 1,000 employees and currently operates from multiple offices in North America and Europe. [ CrunchBase ]

BioElectronics CEO Honored by Chabad at Johns Hopkins Medicine -- FREDERICK, Md., March 13, 2013 /P...

Gensia Pharmaceuticals - Other award recipients at the evening's gala include global leaders in health-care, Dr. Paul Rothman, Dean of the Medical Faculty and CEO of Johns Hopkins Medicine, and Dr. Jeremy Levin and Allan Oberman, respectively, President and CEO of Teva Pharmaceuticals and CEO of Teva Americas ...

Dr. Jeremy M. Levin

Mentioned in this article:
Dr. Jeremy M. Levin

Drugmaker warns morning-after pill ineffective in women over certain weight | The Detroit News

Gensia Pharmaceuticals - Denise Bradley, a spokeswoman for Teva Pharmaceuticals, declined to comment. HRA began the process of consulting with French regulators about changing the pill’s labeling in 2012 and it has taken until now for Europe’s drug regulators to approve the change, Welgryn said. The new warning ...

Denise Bradley

Mentioned in this article:
Denise Bradley

Drugmaker warns on morning-after pill - Europe news - Boston.com

Gensia Pharmaceuticals - Denise Bradley, a spokeswoman for Teva Pharmaceuticals, declined to comment. HRA began the process of consulting with French regulators about changing the pill’s labeling in 2012 and it has taken until now for Europe’s drug regulators to approve the change, Welgryn said. The new warning ...

Denise Bradley

Mentioned in this article:
Denise Bradley

Philly Enterprise Hackathon Awards ,000 in Prize Money | Ben Franklin SEP

Gensia Pharmaceuticals - “I’ve enjoyed the process and am looking forward to turning my concept into reality.” “Teva was pleased to be an inaugural sponsor of and active participant in the Philly Enterprise Hackathon,” said Jon Congleton, Senior Vice President, Global Medicines Group at Teva Pharmaceuticals. “It ...

Jon Congleton

Mentioned in this article:
Jon Congleton

French drug maker warns about morning-after pill - News - JamaicaObserver.com

Gensia Pharmaceuticals - Welgryn said a dose of HRA's drug contains 1.5 mg of levonorgestrel, identical to that found in Plan B One-Step, manufactured by Teva Pharmaceuticals in the US Denise Bradley, a spokeswoman for the company, declined to comment. The Food and Drug Administration is currently reviewing the ...

French drugmaker warns on morning-after pill - Yahoo News

Gensia Pharmaceuticals - Welgryn said a dose of HRA's drug contains 1.5 mg of levonorgestrel, identical to that found in Plan B One-Step, manufactured by Teva Pharmaceuticals in the U.S. Denise Bradley, a spokeswoman for the company, declined to comment. The Food and Drug Administration is currently reviewing ...

CEO of drug maker Teva out ahead job cuts - Yahoo Finance

Gensia Pharmaceuticals - In a statement, Teva said its board of directors and President and CEO Jeremy Levin had agreed for him to step down. It gave no reason for the resignation, but the shakeup exposed cracks in the leadership of the world's largest generic drug maker. The company's statement was quickly ...

Dr. Jeremy M. Levin

Mentioned in this article:
Dr. Jeremy M. Levin

PARIS: Drugmaker warns on morning-after pill | Business | NewsObserver.com

Gensia Pharmaceuticals - Denise Bradley, a spokeswoman for Teva Pharmaceuticals, declined to comment. HRA began the process of consulting with French regulators about changing the pill's labeling in 2012 and it has taken until now for Europe's drug regulators to approve the change, Welgryn said. The new warning ...

Plan B's Problem With Heavier Women Isn't News in Europe - Businessweek

Gensia Pharmaceuticals - “The agency will then determine what, if any, labeling changes to approved emergency contraceptives are warranted.” Teva Pharmaceuticals, the maker of Plan B, declined to comment on any discussions it may be having with the FDA, and spokeswoman Denise Bradley wrote in an e-mail: “The ...

Join Newsle to find out when Suggy Chrai makes the news.

As a Newsle member, you’ll be able to:

  • Get alerts on Suggy Chrai
  • See news articles & blog posts about Suggy Chrai
  • Follow your friends & colleagues in the news
This profile only includes publicly available information. Questions or comments? Contact Us
Freebase CC-BY
Data from Freebase, licensed under CC-BY
Source: CrunchBase
Data from Wikipedia, licensed under the GFDL

People Directory - Browse people by last name:

  1. a
  2. b
  3. c
  4. d
  5. e
  6. f
  7. g
  8. h
  9. i
  10. j
  11. k
  12. l
  13. m
  14. n
  15. o
  16. p
  17. q
  18. r
  19. s
  20. t
  21. u
  22. v
  23. w
  24. x
  25. y
  26. z
  27. more